Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA's Updated Guidance On Monitoring Off-Label Use Of Medicines Expected By Year End

This article was originally published in SRA

Executive Summary

The European Medicines Agency is expected to finalize by the end of this year revisions to its policy on how drug companies should record and report off-label use of medicines not associated with an adverse reaction.